Comparison of Comparison of Ropivacaine and Liposomal Bupivacaine for Total Knee Arthroplasty
Status:
Withdrawn
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This is a randomized prospective outcomes study comparing two groups of patients. One group
will receive liposomal bupivacaine for a periarticular injection. The other will receive
ropivacaine for periarticular injection for pain relief after Total Knee Arthroplasty. the
primary objective of this study is to determine if liposomal bupivacaine provides superior
pain control (decreased maximal pain scores within the first 72 hours post surgery) when
compared to ropivacaine when injected in a periarticular injection.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute